الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 124 |  |  |
| | | from | 124 | | |
Abstract
Hepatitis C virus (HCV) is a serious health problem worldwide that causes chronic infection in up to 85% of cases and can later progress to active liver disease, liver failure, or primary hepatocellular carcinoma. Egypt has the highest prevalence of HCV infection where 14.9 % of Egyptian populations are anti- HCV positive. The effectiveness of the current therapy for HCV (pegylated interferon-α/ribavirin) combination ranges from 45-65%. In addition, it is very costly with many serious adverse effects.